Skip to Main Content

Paper Details

The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.
Transfusion
16
2022
Children, Corona Virus-2, SARS-, SARS-CoV-2, Severe Acute Respiratory Syndrome, blood, blood donors, cancer, children, infants, patients, sickle cell disease, thalassemia
Author NameAffiliation
Cassandra D JosephsonEmory University School of Medicine
Simone A Glynnand Blood Institute, National Institutes of Health
Michael P BuschVitalant Research Institute, University of California San Francisco
Carla Luana DinardoFaculdade de Medicina da Universidade de Sao and Fundacao Pro-Sangue
Jeanne E HendricksonYale University School of Medicine
Eldad A HodColumbia University Irving Medical Center
Naomi L C LubanChildren's Research National Institute, Children's National Hospital
Philip J NorrisVitalant Research Institute, University of California San Francisco
Brian CusterVitalant Research Institute, University of California San Francisco
Bruce S Sachais
Bryan R Spencer
Mars StoneVitalant Research Institute, University of California San Francisco
Steven KleinmanUniversity of British Columbia
  • 1 - 13

Datasets

Release 1.2